
Shares of Granules India GRAN.NS rise 2.8% to 580.80 rupees
Paracetamol maker's Q3 profit up 28% driven by strong demand in its key European and North American markets
Co's Q3 consol profit up to 1.5 billion rupees vs 1.18 billion rupees y/y
North America, which generates about two-thirds of the firm's revenue, logged a 14% jump in sales; Europe sales, which contribute 19% to topline, more than doubled
Current production coming back on stream, ramp-up in new launches in the U.S. and other geographies, coupled with improved volumes- Dolat Capital
GRAN down nearly 3% so far in January